IL6 and neoplasm: Notably, TERT deficiency and dysfunctional telomeres reduced peripheral IL6 and TNF levels, as well as expression of inflammation and tumor immunosuppression markers Tnf, Ifng, IL10 and PD-1 upon LLC challenge.